A guideline-focused teaching lecture covering classification, diagnostic work-up and treat-to-target

An expert overview of pathomechanism and the emerging therapeutic pipeline,

An expert overview of pathomechanism and the emerging therapeutic pipeline,

SETTING THE SCENE JAK1 inhibition in AD has been validated

SETTING THE SCENE Both JAK1 inhibitors and dupilumab produce impressive

SETTING THE SCENE Facial AD in children with skin of